Kymera Therapeutics (KYMR) Insider Trading & Ownership $46.44 -0.86 (-1.82%) (As of 09/18/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Kymera Therapeutics (NASDAQ:KYMR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.82%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2.52 MNumber OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$40.18 M Get KYMR Insider Trade Alerts Want to know when executives and insiders are buying or selling Kymera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KYMR Insider Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Kymera Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/17/2024Pamela EspositoDirectorSell13,500$48.28$651,780.00 8/26/2024Jeffrey W. AlbersDirectorSell5,000$49.10$245,500.00 7/16/2024Jared GollobInsiderSell23,145$45.81$1,060,272.45 7/9/2024Bruce BoothDirectorSell453,960$38.21$17,345,811.60 6/12/2024Bruce BoothDirectorSell16,740$35.45$593,433.00 6/7/2024Joanna HorobinDirectorSell8,500$32.99$280,415.00 Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER…3/15/2024Bruce BoothDirectorSell71,764$40.46$2,903,571.44 3/13/2024Bruce BoothDirectorSell139,255$42.23$5,880,738.65 3/13/2024Venture Fund X L.P. AtlasMajor ShareholderSell115,090$42.23$4,860,250.70 3/11/2024Bruce BoothDirectorSell51,184$42.85$2,193,234.40 3/11/2024Venture Fund X L.P. AtlasMajor ShareholderSell42,302$42.85$1,812,640.70 3/4/2024Bruce N JacobsCFOSell3,934$41.86$164,677.24 2/21/2024Jeffrey W. AlbersDirectorSell4,385$39.05$171,234.25 2/9/2024Jared GollobInsiderSell46,137$35.50$1,637,863.50 1/23/2024Jeffrey W. AlbersDirectorSell10,000$30.05$300,500.00 1/4/2024Ellen ChiniaraInsiderSell3,295$22.58$74,401.10 11/2/2023Bvf Partners L P/IlDirectorBuy216,406$11.64$2,518,965.84 (Data available from 1/1/2013 forward) KYMR Insider Trading Activity - Frequently Asked Questions Who is on Kymera Therapeutics's Insider Roster? The list of insiders at Kymera Therapeutics includes Bruce Booth, Bruce N Jacobs, Bvf Partners L P/Il, Ellen Chiniara, Jared Gollob, Jeffrey W. Albers, Joanna Horobin, Nello Mainolfi, Pamela Esposito, and Venture Fund X L.P. Atlas. Learn more on insiders at KYMR. What percentage of Kymera Therapeutics stock is owned by insiders? 15.82% of Kymera Therapeutics stock is owned by insiders. Learn more on KYMR's insider holdings. Which Kymera Therapeutics insiders have been buying company stock? The following insider purchased KYMR shares in the last 24 months: Bvf Partners L P/Il ($3,179,833.74). How much insider buying is happening at Kymera Therapeutics? Insiders have purchased a total of 238,516 KYMR shares in the last 24 months for a total of $3,179,833.74 bought. Which Kymera Therapeutics insiders have been selling company stock? The following insiders have sold KYMR shares in the last 24 months: Bruce Booth ($50,893,897.95), Bruce N Jacobs ($207,147.24), Ellen Chiniara ($74,401.10), Jared Gollob ($2,698,135.95), Jeffrey W. Albers ($717,234.25), Joanna Horobin ($280,415.00), Pamela Esposito ($651,780.00), and Venture Fund X L.P. Atlas ($24,492,706.16). How much insider selling is happening at Kymera Therapeutics? Insiders have sold a total of 2,303,533 Kymera Therapeutics shares in the last 24 months for a total of $80,015,717.65 sold. More Insider Trading Tools from MarketBeat Related Companies: BEAM Insider Trading NRIX Insider Trading REPL Insider Trading EDIT Insider Trading ALVR Insider Trading ATRA Insider Trading CTLT Insider Trading ROIV Insider Trading ITCI Insider Trading ELAN Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:KYMR) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Kymera Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Kymera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.